Sironax Usa, Inc.

This completed early-stage study tested whether an experimental drug called SIR1-365 is safe for hospitalized patients with severe COVID-19. Researchers enrolled 45 adults to receive either the drug or a placebo for 14 days, monitoring side effects and whether it helped reduce in…